{"id":"W2553350762","doi":"10.1182/blood.v116.21.182.182","title":"Remission Rates In Childhood Acute Myeloid Leukemia (AML) Utilizing a Dose-Intensive Induction Regimen with or without Gemtuzumab Ozogamicin (GO): Initial Results From the Children's Oncology Group Phase III Trial, AAML0531","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine; Gemtuzumab ozogamicin; Cytarabine; Regimen; Internal medicine; Etoposide; Induction chemotherapy; Transplantation; Myeloid leukemia; Surgery; Gastroenterology; Pediatrics; Chemotherapy; CD33; Stem cell","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002179569,0.0002897498,0.0008195516,0.0002318526,0.0001778452,0.0004594086,0.0003945649,0.0005698071,0.001290604],"category_scores_gemma":[0.001312225,0.000179066,0.0008142883,0.000295697,0.0003821026,0.0003886433,0.0003282295,0.001438196,0.0001822055],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005192346,"about_ca_system_score_gemma":0.0005635531,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007348676,"about_ca_topic_score_gemma":0.001864883,"domain_scores_codex":[0.9993512,0.0003908537,0.00004464049,0.00007006065,0.00006888105,0.0000744037],"domain_scores_gemma":[0.9989028,0.000336242,0.0003034637,0.0001192794,0.00002870662,0.0003096025],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7996367,0.01463236,0.03232448,0.0004090476,0.001183945,0.0001130632,0.0002365544,0.002949008,0.02120792,0.0004469397,0.003904196,0.1229558],"study_design_scores_gemma":[0.4212462,0.3523818,0.2064527,0.00007875996,0.00169725,0.0004417227,0.0001052518,0.002418681,0.009129332,0.0005567974,0.005455973,0.00003548029],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975939,0.001034481,0.0001178199,0.0001604028,0.00002222229,0.0001435411,0.0003495692,0.00001287141,0.0005650882],"genre_scores_gemma":[0.9975007,0.0005163825,0.000316509,0.0002293331,0.00005213374,0.000142808,0.0007852046,0.000004634031,0.0004522957],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002179569,"threshold_uncertainty_score":0.01152676,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02887540553746439,"score_gpt":0.3402817247852424,"score_spread":0.311406319247778,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}